Angela McCool-Pearson
Obstetrics & Gynecology · Fairhope, ALNPI 1154445724
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $45,450 of the $57,136 with a category attached, or 79.5%. AbbVie accounts for 92.9% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2019 at $28,861 and has fallen 99.9% since, to $38 in 2025. Among obstetrics & gynecology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 184 payments — averaging $310.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$53K
- Therapeuticsmd, Inc.$1K
- Applied Medical Resources Corporation$1K
- Coloplast$436
- Intuitive Surgical$277
- Galderma Laboratories, L.p.$201
- plus $532 from 19 others
Across 124 payments — averaging $1815.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$225K
What the payments were for
- Consulting fees$1,2002%
- Speaking & faculty fees$45,45080%
- Travel & lodging$6,96112%
- Food & beverage$3,4016%
- Education$1240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 113 | $53,065 |
| Therapeuticsmd, Inc. | 19 | $1,448 |
| Applied Medical Resources Corporation | 3 | $1,177 |
| Coloplast | 2 | $436 |
| Intuitive Surgical | 8 | $277 |
| Galderma Laboratories, L.p. | 9 | $201 |
| Pfizer | 6 | $98 |
| Astellas Pharma US Inc | 3 | $59 |
| Bausch Health US, LLC | 2 | $59 |
| Merz North America, Inc. | 2 | $40 |
| Mylan Pharmaceuticals Inc. | 2 | $35 |
| Agile Therapeutics, Inc. | 2 | $29 |
| Millicent US Inc | 1 | $22 |
| Organon | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Mayne Pharma Commercial LLC | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Evofem Biosciences, Inc. | 1 | $15 |
| Avion Pharmaceuticals | 1 | $14 |
| Duchesnay USA Incorporated | 1 | $14 |
| Myovant Sciences Inc. | 1 | $14 |
| Meditrina | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| AMAG Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$48,102
- ORIAHNN$4,550
- GelPOINT V-Path$2,201
- ANNOVERA$1,200
- ALTIS$414
How this compares
$57,136 in reported general payments places this provider in the 95th percentile of 537 obstetrics & gynecology providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 11 | $14,433 |
| PremarinEstrogens, Conjugated | 26 | $8,491 |
| Estradiol | 124 | $8,102 |
| ProgesteroneProgesterone, Micronized | 49 | $3,679 |
| Estradiol (Twice Weekly)Estradiol | 21 | $3,165 |
| ValacyclovirValacyclovir Hcl | 17 | $623 |
| Clobetasol Propionate | 12 | $340 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $59 | $14,43311 claims |
| PfizerPremarin | $98 | $8,49126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 537 obstetrics & gynecology providers in Alabama.
Other obstetrics & gynecology in Fairhope
- Marshall ShoemakerFairhope$10K
- Mary WellsFairhope$7K
- Jennifer LambertFairhope$5K
- Leslie EvansFairhope$5K
- Gary NelsonFairhope$5K
- Theodore TsaltasBirmingham$853K
- Richard BrownGulf Shores$429K
- Timothy HughesMobile$149K
- Allison CalhounMobile$132K
- Praful PatelDothan$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.